Symptomatic adrenal insufficiency during inhaled corticosteroid treatment

Archives of Disease in Childhood

Volumn 85, Issue 4, 2001, Pages 330-333

  Patel, L ^a   Wales, J K ^b   Kibirige, M S ^c   Massarano, A A ^d   Couriel, J M ^a   Clayton, P E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d TAMESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Adrenal insufficiency; Asthma; Hypoglycaemia; Inhaled corticosteroid

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE;

ADRENAL INSUFFICIENCY; ARTICLE; ASTHMA; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PEDIATRICIAN; PRIORITY JOURNAL; WEIGHT GAIN;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; BUDESONIDE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROCORTISONE; MALE;

EID: 0034809478     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.85.4.330     Document Type: Article

References (13)

1. Systemic adverse effects of inhaled corticosteroid therapy. A systematic review and meta-analysis
2. The role of inhaled corticosteroids in children with asthma
3. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate
4. Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate
5. Acute adrenal insufficiency after discontinuation of inhaled corticosteroid therapy
6. The British Guidelines on Asthma Management. 1995 Review and Position Statement
7. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of literature
8. Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids
9. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate
10. Tissue specificity of glucocorticoid sensitivity in healthy adults
11. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects
12. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension
13. Steroid resistance in asthma